Navigation Links
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
Date:7/13/2010

and demand for the Company's new pharmaceutical products;
  • the introduction and impact of competitive products and pricing, including as a result of so-called authorized generic drugs or compounded drugs;
  • new product development and launch, including the possibility that any product launch may be delayed;
  • reliance on key strategic acquisitions;
  • the availability of raw materials and/or products manufactured for the Company under contract manufacturing agreements with third parties;
  • the regulatory environment, including regulatory agency and judicial actions and changes in applicable laws or regulations;
  • fluctuations in revenues;
  • the difficulty of predicting international regulatory approvals, including timing;
  • the difficulty of predicting the pattern of inventory movements by the Company's customers;
  • the impact of competitive response to the Company's sales, marketing and strategic efforts, including introduction or potential introduction of generic or competing products against products sold by the Company and its subsidiaries;
  • risks that the Company may not ultimately prevail in litigation, including product liability lawsuits and challenges to its intellectual property rights by actual or potential competitors or to its ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries including without limitation the litigation and claims referred to in Note 18 – "Commitments and Contingencies" of the Notes to the Consolidated Financial Statements in the Form 10-Q;
  • the possibility that our current estimates of the financial effect of certain announced product recalls could prove to be incorrect;
  • whether any product recalls or product introductions result in litigation, agency action or m
    '/>"/>

  • SOURCE K-V Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Ferring Pharmaceuticals FIRMAGON® Named Official Sponsor of Ed Randalls Bat for the Cure
    2. Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc.
    3. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
    4. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
    5. K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010
    6. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
    7. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
    8. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
    9. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
    10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
    11. EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
    (Date:3/27/2015)... 2015  WebMD Health Corp. (NASDAQ: ... information, today announced an exclusive White House ... Plan for Combating Antibiotic-Resistant Bacteria . During ... and importance of addressing antibiotic-resistant bacteria and ... The WebMD interview, available online ...
    (Date:3/26/2015)... Huntington Memorial Hospital is the first facility ... valve replacement (TAVR), a minimally invasive replacement of heart ... to replace an aortic valve without a chest incision ... The procedure is performed by a dedicated Huntington ... Durairaj , MD, interventional cardiologist and Robbin Cohen ...
    Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
    ... , July 1 Samplify Systems, Inc., a leading provider of ... providing a local presence to better serve customers interested in the company,s ... Xu , who joins Samplify as Country Sales Director.   , ... (Logo: http://photos.prnewswire.com/prnh/20080411/AQF028LOGO ) , ...
    ... July 1 Caraco Pharmaceutical Laboratories, Ltd. ... tartrate capsules. These products, approved by the US Food ... Drug Application (ANDA), are therapeutically equivalent to Exelon® capsules ... mild to moderate Alzheimer,s dementia and mild to moderate ...
    Cached Medicine Technology:Samplify Expands Global Presence; Opens China Office 2Samplify Expands Global Presence; Opens China Office 3Samplify Expands Global Presence; Opens China Office 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules 2
    (Date:3/27/2015)... While deep learning was the topic of many ... , the CEO of one start-up spoke passionately about using ... well beyond the generally-agreed ceiling of 120 years. , Insilico ... of 12 companies recognized as the hottest GPU-powered startups in ... GTC Emerging Companies Summit have business models focused on ...
    (Date:3/27/2015)... Detroit, Michigan (PRWEB) March 27, 2015 ... Field, LiveToBeSober.org, along with former Detroit Lions wide ... informal luncheon and educational presentation on substance abuse, ... legislation. Among those who attended were pastors, ministers ... civic leaders and other distinguished guests. , “Our ...
    (Date:3/27/2015)... 27, 2015 GenSight, the leading Enterprise ... Sean Fitzgerald, a former technology and financial executive to ... Interim Chief Financial Officer. , Mr Fitzgerald was most ... EverFi, backed by Amazon founder and CEO Jeff Bezos, ... Prior to EverFi, he was a Senior Vice President ...
    (Date:3/27/2015)... WA (PRWEB) March 27, 2015 When ... can be hard to know where to begin. The ... experienced Seattle trucking accident attorney, offers accident victims a ... and legal assistance to ensure their personal injury claim ... begins by describing the first actions that should be ...
    (Date:3/27/2015)... MN (PRWEB) March 27, 2015 ... Minnesotans for Healthy Kids Coalition Lobby Day to ... Statewide Health Improvement Program (SHIP). Everlast Climbing ... 2015 PE Bill SF343/HF498 which would strengthen physical ... annual student assessments and other measures to strengthen ...
    Breaking Medicine News(10 mins):Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2
    ... off ,superbugs, , , MONDAY, April 7 (HealthDay News) -- Call ... alligator blood could serve as the basis for new antibiotics ... , The research is in its early stages -- extracts ... -- and there,s no guarantee that it will work in ...
    ... Association Intervention Tool Kit Reduces Patient ... Injuries/Repeat Visits and Risky Drinking, DES ... Alcohol Screening Day, 360 nurses in emergency departments,nationwide will ... intervention tool kit designed to address alcohol use,problems with ...
    ... science education, scientific research, and the role science should play in ... ... NEW YORK, April 7, 2008 Since its launch in October,2006, the ... human health issues facing the 21st century, including the,brain, the human genome, ...
    ... NEW YORK, April 7, 2008 In celebration ... Tuesday, April 15, a biodiesel-fueled,eco-salon and spa bus ... around,Southern California from Tuesday, April 15, 2008 - ... shopping areas and attractions., The general public ...
    ... April 7, 2008 Edmond Medical Center and,ophthalmologists M. ... Regional Eye Associates, will once again participate in the ... surgeries,for those who cannot afford to pay., Appointments ... physicians,office. If the patient qualifies for the cataract surgery ...
    ... that estrogen replacement therapy (ERT) may increase the risk of ... adverse effects of ERT are related to the doses used. ... increased problems in the kidney and heart. These results suggest ... womans overall health. , The study, Dose-Response Effect of ...
    Cached Medicine News:Health News:Gator Blood May Be New Source of Antibiotics 2Health News:Gator Blood May Be New Source of Antibiotics 3Health News:Emergency Departments Nationwide Institute New Alcohol Screening and Intervention Process 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 3Health News:ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments 2Health News:Edmond Medical Center to Provide Free Cataract Surgeries 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: